12-101723803-T-C
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_020244.3(CHPT1):c.1021T>C(p.Phe341Leu) variant causes a missense change. The variant allele was found at a frequency of 0.00266 in 1,544,868 control chromosomes in the GnomAD database, including 77 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0032 ( 7 hom., cov: 32)
Exomes 𝑓: 0.0026 ( 70 hom. )
Consequence
CHPT1
NM_020244.3 missense
NM_020244.3 missense
Scores
3
8
7
Clinical Significance
Conservation
PhyloP100: 5.93
Genes affected
CHPT1 (HGNC:17852): (choline phosphotransferase 1) Enables diacylglycerol cholinephosphotransferase activity. Involved in phosphatidylcholine biosynthetic process and platelet activating factor biosynthetic process. Predicted to be located in Golgi membrane. Predicted to be active in Golgi apparatus and endoplasmic reticulum membrane. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.008994997).
BP6
Variant 12-101723803-T-C is Benign according to our data. Variant chr12-101723803-T-C is described in ClinVar as [Benign]. Clinvar id is 782716.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAdExome4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.0534 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00319 AC: 486AN: 152220Hom.: 8 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
486
AN:
152220
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00655 AC: 1597AN: 243758 AF XY: 0.00619 show subpopulations
GnomAD2 exomes
AF:
AC:
1597
AN:
243758
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00260 AC: 3626AN: 1392530Hom.: 70 Cov.: 23 AF XY: 0.00252 AC XY: 1758AN XY: 696608 show subpopulations
GnomAD4 exome
AF:
AC:
3626
AN:
1392530
Hom.:
Cov.:
23
AF XY:
AC XY:
1758
AN XY:
696608
Gnomad4 AFR exome
AF:
AC:
4
AN:
31114
Gnomad4 AMR exome
AF:
AC:
208
AN:
43512
Gnomad4 ASJ exome
AF:
AC:
0
AN:
25638
Gnomad4 EAS exome
AF:
AC:
2154
AN:
38944
Gnomad4 SAS exome
AF:
AC:
189
AN:
83294
Gnomad4 FIN exome
AF:
AC:
446
AN:
53190
Gnomad4 NFE exome
AF:
AC:
431
AN:
1053714
Gnomad4 Remaining exome
AF:
AC:
190
AN:
57802
Heterozygous variant carriers
0
158
316
475
633
791
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
50
100
150
200
250
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.00318 AC: 484AN: 152338Hom.: 7 Cov.: 32 AF XY: 0.00372 AC XY: 277AN XY: 74496 show subpopulations
GnomAD4 genome
AF:
AC:
484
AN:
152338
Hom.:
Cov.:
32
AF XY:
AC XY:
277
AN XY:
74496
Gnomad4 AFR
AF:
AC:
0.0002886
AN:
0.0002886
Gnomad4 AMR
AF:
AC:
0.00228698
AN:
0.00228698
Gnomad4 ASJ
AF:
AC:
0
AN:
0
Gnomad4 EAS
AF:
AC:
0.0528142
AN:
0.0528142
Gnomad4 SAS
AF:
AC:
0.00269374
AN:
0.00269374
Gnomad4 FIN
AF:
AC:
0.00847458
AN:
0.00847458
Gnomad4 NFE
AF:
AC:
0.000779068
AN:
0.000779068
Gnomad4 OTH
AF:
AC:
0.00284091
AN:
0.00284091
Heterozygous variant carriers
0
23
46
69
92
115
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
768
Asia WGS
AF:
AC:
68
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Jun 22, 2018
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Benign
T
BayesDel_noAF
Uncertain
DANN
Uncertain
DEOGEN2
Benign
T;.
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
D;.
MetaRNN
Benign
T;T
MetaSVM
Benign
T
MutationAssessor
Uncertain
M;.
PrimateAI
Uncertain
T
PROVEAN
Pathogenic
D;D
REVEL
Uncertain
Sift
Benign
D;D
Sift4G
Benign
T;T
Polyphen
D;D
Vest4
MutPred
Gain of catalytic residue at F336 (P = 0.0077);Gain of catalytic residue at F336 (P = 0.0077);
MVP
MPC
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Mutation Taster
=91/9
polymorphism
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at